|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Okamoto T, Suzuki Y, Fujishita T, Kitahara
H, Shimamatsu S, Kohno M, Morodomi Y, Kawano D and Maehara Y: The
prognostic impact of the amount of tobacco smoking in non-small
cell lung cancer-differences between adenocarcinoma and squamous
cell carcinoma. Lung Cancer. 85:125–130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gandara DR, Hammerman PS, Sos ML, Lara PN
Jr and Hirsch FR: Squamous cell lung cancer: From tumor genomics to
cancer therapeutics. Clin Cancer Res. 21:2236–2243. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang CC, Fong Y, Lin LC, Que J, Ting WC,
Chang CL, Wu HM, Ho CH, Wang JJ and Huang CI: The age-adjusted
Charlson comorbidity index is a better predictor of survival in
operated lung cancer patients than the Charlson and Elixhauser
comorbidity indices. Eur J Cardiothorac Surg. 53:235–240. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ettinger DS, Wood DE, Aisner DL, Akerley
W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ,
Dobelbower M, et al: Non-small cell lung cancer, version 5.2017,
NCCN clinical practice guidelines in oncology. J Natl Compr Canc
Netw. 15:504–535. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ettinger DS, Akerley W, Borghaei H, Chang
AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R,
Grannis FW Jr, et al: Non-small cell lung cancer, version 2.2013. J
Natl Compr Canc Netw. 11:645–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi A, Zhu G, Wu H, Yu R, Li F and Xu B:
Analysis of clinical and dosimetric factors associated with severe
acute radiation pneumonitis in patients with locally advanced
non-small cell lung cancer treated with concurrent chemotherapy and
intensity-modulated radiotherapy. Radiat Oncol. 5:352010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rimando AM, Kalt W, Magee JB, Dewey J and
Ballington JR: Resveratrol, pterostilbene, and piceatannol in
vaccinium berries. J Agric Food Chem. 52:4713–4719. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Estrela JM, Ortega A, Mena S, Rodriguez ML
and Asensi M: Pterostilbene: Biomedical applications. Crit Rev Clin
Lab Sci. 50:65–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie B, Xu Z, Hu L, Chen G, Wei R, Yang G,
Li B, Chang G, Sun X, Wu H, et al: Pterostilbene inhibits human
multiple myeloma cells via ERK1/2 and JNK pathway in vitro and in
vivo. Int J Mol Sci. 17(pii): E19272016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McCormack D and McFadden D: Pterostilbene
and cancer: Current review. J Surg Res. 173:e53–e61. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prabhakar CN: Epidermal growth factor
receptor in non-small cell lung cancer. Transl Lung Cancer Res.
4:110–118. 2015.PubMed/NCBI
|
|
13
|
Tang Z, Du R, Jiang S, Wu C, Barkauskas
DS, Richey J, Molter J, Lam M, Flask C, Gerson S, et al: Dual
MET-EGFR combinatorial inhibition against T790M-EGFR-mediated
erlotinib-resistant lung cancer. Br J Cancer. 99:911–922. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Zhan C, Ke J, Xue Z, Zhang A, Xu
K, Shen Z, Yu L and Chen L: EGFR kinase domain mutation positive
lung cancers are sensitive to intrapleural perfusion with
hyperthermic chemotherapy (IPHC) complete treatment. Oncotarget.
7:3367–3378. 2016.PubMed/NCBI
|
|
15
|
Zhang H, Li N, Chen Y, Huang LY, Wang YC,
Fang G, He DC and Xiao XY: Protein profile of human lung squamous
carcinoma cell line NCI-H226. Biomed Environ Sci. 20:24–32.
2007.PubMed/NCBI
|
|
16
|
Zang JP and Wei R: Effects of Cx43 gene
modification on the proliferation and migration of the human lung
squamous carcinoma cell line NCI-H226. Genet Mol Res.
14:13110–13119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li K, Dias SJ, Rimando AM, Dhar S, Mizuno
CS, Penman AD, Lewin JR and Levenson AS: Pterostilbene acts through
metastasis-associated protein 1 to inhibit tumor growth,
progression and metastasis in prostate cancer. PLoS One.
8:e575422013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mannal PW, Alosi JA, Schneider JG,
McDonald DE and McFadden DW: Pterostilbene inhibits pancreatic
cancer in vitro. J Gastrointest Surg. 14:873–879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang BY, Huang JY, Cheng CY, Lin CH, Ko J
and Liaw YP: Lung cancer and prognosis in taiwan: A
population-based cancer registry. J Thorac Oncol. 8:1128–1135.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siddiqui IA, Adhami VM, Ahmad N and
Mukhtar H: Nanochemoprevention: Sustained release of bioactive food
components for cancer prevention. Nutr Cancer. 62:883–890. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riboli E, Slimani N and Kaaks R:
Identifiability of food components for cancer chemoprevention. IARC
Sci Publ. 23–31. 1996.PubMed/NCBI
|
|
22
|
Suh N, Paul S, Hao X, Simi B, Xiao H,
Rimando AM and Reddy BS: Pterostilbene, an active constituent of
blueberries, suppresses aberrant crypt foci formation in the
azoxymethane-induced colon carcinogenesis model in rats. Clin
Cancer Res. 13:350–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Riche DM, McEwen CL, Riche KD, Sherman JJ,
Wofford MR, Deschamp D and Griswold M: Analysis of safety from a
human clinical trial with pterostilbene. J Toxicol.
2013:4635952013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pei HL, Mu DM and Zhang B: Anticancer
activity of pterostilbene in human ovarian cancer cell lines. Med
Sci Monit. 23:3192–3199. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kong Y, Chen G, Xu Z, Yang G, Li B, Wu X,
Xiao W, Xie B, Hu L, Sun X, et al: Pterostilbene induces apoptosis
and cell cycle arrest in diffuse large B-cell lymphoma cells. Sci
Rep. 6:374172016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wawszczyk J, Kapral M, Hollek A and
Weglarz L: In vitro evaluation of antiproliferative and cytotoxic
properties of pterostilbene against human colon cancer cells. Acta
Pol Pharm. 71:1051–1055. 2014.PubMed/NCBI
|
|
27
|
Mann MB and Kaldis P: Cell cycle
transitions and Cdk inhibition in melanoma therapy: Cyclin' through
the options. Cell Cycle. 10:13492011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aleo E, Henderson CJ, Fontanini A, Solazzo
B and Brancolini C: Identification of new compounds that trigger
apoptosome-independent caspase activation and apoptosis. Cancer
Res. 66:9235–9244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schneider JG, Alosi JA, McDonald DE and
McFadden DW: Pterostilbene inhibits lung cancer through induction
of apoptosis. J Surg Res. 161:18–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen RJ, Ho CT and Wang YJ: Pterostilbene
induces autophagy and apoptosis in sensitive and chemoresistant
human bladder cancer cells. Mol Nutr Food Res. 54:1819–1832. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aral K, Aral CA and Kapila Y: The role of
caspase-8, caspase-9, and apoptosis inducing factor in periodontal
disease. J Periodontol. 90:288–294. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan MH, Chang YH, Badmaev V, Nagabhushanam
K and Ho CT: Pterostilbene induces apoptosis and cell cycle arrest
in human gastric carcinoma cells. J Agric Food Chem. 55:7777–7785.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ruiz MJ, Fernandez M, Pico Y, Mañes J,
Asensi M, Carda C, Asensio G and Estrela JM: Dietary administration
of high doses of pterostilbene and quercetin to mice is not toxic.
J Agric Food Chem. 57:3180–3186. 2009. View Article : Google Scholar : PubMed/NCBI
|
